Clues on cancer from a zebrafish model of melanoma

Key points
- Melanoma, the most lethal form of skin cancer, is an epidemic among cancers; it claims thousands of lives every year.
- By studying how a particular human gene often mutated in melanoma influences melanoma development in a fish species, researchers have created a genetic model for understanding how melanoma develops humans.
- An effective way to study gene function is to use an animal model, such as zebrafish, a small (3 cm) vertebrate.
- Past work from The Cancer Genome Project of Wellcome Trust Sanger Institute included the significant finding that the gene encoding a particular protein, BRAF kinase, is mutated in more than 65% of melanomas.
Melanoma, the most lethal form of skin cancer, is an epidemic among cancers; it claims thousands of lives every year. Despite advances in cancer genetics and treatments, current therapies are only mildly effective once melanoma has become metastatic. Understanding the genetic and environmental influences that lead to melanoma will contribute to therapeutic advancement.
By studying how a particular human gene often mutated in melanoma influences melanoma development in a fish species, researchers have created a genetic model for understanding how melanoma develops humans.
An effective way to study gene function is to use an animal model, such as zebrafish, a small (3 cm) vertebrate. Within the last two decades, the zebrafish species has been used to study a wide range of diseases, in part owing to genetic similarities between humans and fish.
Past work from The Cancer Genome Project of Wellcome Trust Sanger Institute included the significant finding that the gene encoding a particular protein, BRAF kinase, is mutated in more than 65% of melanomas. Remarkably, one mutation, V600E, is found in more than 80% of cases. BRAF mutations are also found in nevi (commonly known as moles) and may represent a critical step in the initiation of melanoma development.
In the new work reported this week, Drs. Elizabeth Patton, Leonard Zon, and colleagues at Children's Hospital Boston & Harvard Medical School have advanced our understanding of the contribution of BRAF mutation to melanoma. By engineering zebrafish to express the mutated form of human BRAF in zebrafish melanocytes, the authors show that BRAF expression induces dramatic black pigmentation in the skin of the fish. Strengthening their evidence that BRAF mutation may be important for the initiation of melanoma development, the researchers found that when these fish are deficient for a cancer-protective protein called p53, they develop an aggressive melanoma. Histological analysis shows a high similarity between zebrafish and human melanomas, further strengthening the potential utility of the fish model for understanding the human disease. The zebrafish genetic model of melanoma shows that human BRAF mutations are sufficient for formation of large ectopic nevi that are highly melanoma-prone and provides a new tool for the exploration of melanoma genetics and drug development.
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsRoche melanoma pill spurs growth of less harmful cancers
A new study helps explain why up to a third of advanced melanoma patients who take Roche Holding's pill Zelboraf develop a less deadly form of skin cancer known as cutaneous squamous cell carcinoma, and even points to a…
20 January 2012
NewsProspective surveillance model emerges as standard of care for breast cancer treatment
Early diagnosis and treatment of breast cancer-related lymphedema by a physical therapist can significantly reduce costs and the need for intensive rehabilitation, according to an article published in the January issue…
8 January 2012
NewsMoffitt Cancer Center Researchers Find More Clues To Causes Of Breast Cancer
Publishing in the current issue of The Journal of Biological Chemistry (Vol. 286, No 43), researchers at Moffitt Cancer Center in Tampa, Fla., have discovered additional mechanisms of "Akt" activation and suggest a…






